Finance

Results: 11221-11232 of 49208

Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 2025

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis

Navatar Launches AI-Powered CRM Operating Model On Salesforce for Alternative Asset Managers

PR Newswire associated0

THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS

PR Newswire associated0

AIRS Medical to Showcase SwiftMR™ Live at ECR 2026

Polyplastics Develops New PLASTRON(R) LFT Grades with Post-consumer Recycled Content

Pew Applauds Milestone Ratification of International Treaty to Improve Safety at Sea

Luxfer Delivers Strong Full-Year 2025 Profitability and Cash Generation

PR Newswire associated0

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance

IGI Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results and Declares Ordinary Common Share Dividend

Alkermes to Present at the TD Cowen 46th Annual Health Care Conference